Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)

China flag China · Delayed Price · Currency is CNY
32.81
-0.91 (-2.70%)
Mar 9, 2026, 3:00 PM CST
-15.14%
Market Cap 10.37B
Revenue (ttm) 1.94B
Net Income (ttm) 327.00M
Shares Out 316.05M
EPS (ttm) 1.04
PE Ratio 31.55
Forward PE 16.16
Dividend 0.64 (1.91%)
Ex-Dividend Date n/a
Volume 4,405,002
Average Volume 3,692,454
Open 33.55
Previous Close 33.72
Day's Range 32.78 - 34.06
52-Week Range 29.86 - 50.86
Beta 0.33
RSI 40.68
Earnings Date Apr 30, 2026

About SHA:688076

Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 2,247
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688076
Full Company Profile

Financial Performance

In 2025, SHA:688076's revenue was 1.94 billion, an increase of 19.57% compared to the previous year's 1.62 billion. Earnings were 327.00 million, a decrease of -19.14%.

Financial Statements

News

There is no news available yet.